# Understanding surface potential dynamics of passivated perovskites via Kelvin Probe Force Microscopy

Preprint · Rehmat Sood-Goodwin, Xue-Li Cao, Benjamin C. Kinvig, Robert D. J. Oliver, Yen-Hung Lin, Nic Mullin, Alexandra J. Ramadan

- Archive id: arxiv:2607.07221
- Published: 2026-07-08
- arXiv: https://arxiv.org/abs/2607.07221
- Citations: 0
- Source URL: https://arxiv.org/abs/2607.07221
- PDF: https://arxiv.org/pdf/2607.07221
- Provenance: arxiv

## Abstract

Molecular passivation has become central to reducing photovoltage losses in metal-halide perovskite solar cells, but its electronic action is still often inferred from device-level metrics rather than directly resolved at the nanoscale. Here, we use amplitude-modulated Kelvin probe force microscopy to examine how \[3-(2-aminoethylamino)propyl\]trimethoxysilane (AEAPTMS) modifies the surface potential and photovoltage dynamics of mixed-cation, mixed-halide perovskite thin films. AEAPTMS homogenises the dark contact potential difference (CPD), narrowing its distribution from ~45.7 to ~14.6 mV without obvious morphological changes. Under illumination, passivated films show a larger steady-state surface photovoltage (SPV) and faster stabilisation, with the SPV increasing from ~345 to ~417 mV and the stabilisation time constant decreasing from ~840 to ~470 s. Wavelength-dependent SPV further indicates reduced sub-bandgap electronic disorder. By separating grain-boundary and grain-interior contributions, we show that AEAPTMS suppresses grain-boundary potential barriers, linking amino-silane passivation to a more homogeneous and stable carrier landscape.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Perovskite & Tandem Photovoltaics](https://space-kitty.com/topics/advanced-photovoltaics)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.